UBS Group’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1M | Buy |
267,340
+263,211
| +6,375% | +$986K | ﹤0.01% | 5479 |
|
|
2025
Q4 | $16.5K | Sell |
4,129
-155,706
| -97% | -$566K | ﹤0.01% | 7915 |
|
|
2025
Q3 | $547K | Buy |
159,835
+49,876
| +45% | +$129K | ﹤0.01% | 6030 |
|
|
2025
Q2 | $209K | Sell |
109,959
-57,947
| -35% | -$237K | ﹤0.01% | 6693 |
|
|
2025
Q1 | $1.19M | Buy |
167,906
+137,137
| +446% | +$1.89M | ﹤0.01% | 5135 |
|
|
2024
Q4 | $678K | Buy |
30,769
+22,065
| +254% | +$352K | ﹤0.01% | 5634 |
|
|
2024
Q3 | $175K | Buy |
8,704
+6,636
| +321% | +$138K | ﹤0.01% | 5975 |
|
|
2024
Q2 | $36K | Sell |
2,068
-2,235
| -52% | -$73.1K | ﹤0.01% | 6941 |
|
|
2024
Q1 | $179K | Buy |
4,303
+4,262
| +10,395% | +$119K | ﹤0.01% | 5933 |
|
|
2023
Q4 | $1.03K | Sell |
41
-4,717
| -99% | -$115K | ﹤0.01% | 8428 |
|
|
2023
Q3 | $156K | Buy |
4,758
+4,674
| +5,564% | +$204K | ﹤0.01% | 5537 |
|
|
2023
Q2 | $4.9K | Sell |
84
-3,249
| -97% | -$167K | ﹤0.01% | 7492 |
|
|
2023
Q1 | $87K | Buy |
+3,333
| New | +$97.7K | ﹤0.01% | 6020 |
|
|
2022
Q4 | – | Sell |
-318
| Closed | -$16K | – | 11202 |
|
|
2022
Q3 | $16K | Buy |
318
+277
| +676% | +$9.57K | ﹤0.01% | 7719 |
|
|
2022
Q2 | $1K | Sell |
41
-1
| -2% | -$38 | ﹤0.01% | 9983 |
|
|
2022
Q1 | $2K | Buy |
42
+20
| +91% | +$1.15K | ﹤0.01% | 9682 |
|
|
2021
Q4 | $2K | Buy |
+22
| New | +$2.78K | ﹤0.01% | 9838 |
|
|
2021
Q3 | – | Sell |
-4
| Closed | -$1K | – | 10148 |
|
|
2021
Q2 | $1K | Sell |
4
-129
| -97% | -$32.4K | ﹤0.01% | 9199 |
|
|
2021
Q1 | $34K | Sell |
133
-381
| -74% | -$100K | ﹤0.01% | 6906 |
|
|
2020
Q4 | $99K | Buy |
514
+142
| +38% | +$27.9K | ﹤0.01% | 5697 |
|
|
2020
Q3 | $75K | Buy |
372
+202
| +119% | +$48.4K | ﹤0.01% | 5361 |
|
|
2020
Q2 | $48K | Sell |
170
-139
| -45% | -$38.1K | ﹤0.01% | 5897 |
|
|
2020
Q1 | $93K | Sell |
309
-180
| -37% | -$51.1K | ﹤0.01% | 5349 |
|
|
2019
Q4 | $157K | Buy |
489
+187
| +62% | +$67.1K | ﹤0.01% | 5755 |
|
|
2019
Q3 | $115K | Buy |
302
+260
| +619% | +$103K | ﹤0.01% | 5690 |
|
|
2019
Q2 | $19K | Buy |
42
+36
| +600% | +$18.3K | ﹤0.01% | 6656 |
|
|
2019
Q1 | $3K | Sell |
6
-33
| -85% | -$18.2K | ﹤0.01% | 7352 |
|
|
2018
Q4 | $16K | Buy |
39
+20
| +105% | +$7.63K | ﹤0.01% | 6954 |
|
|
2018
Q3 | $5K | Sell |
19
-77
| -80% | -$32.7K | ﹤0.01% | 7513 |
|
|
2018
Q2 | $63K | Sell |
96
-23
| -19% | -$75.3K | ﹤0.01% | 5815 |
|
|
2018
Q1 | $491K | Buy |
119
+1
| +0.8% | +$2.91K | ﹤0.01% | 4220 |
|
|
2017
Q4 | $270K | Buy |
+118
| New | +$298K | ﹤0.01% | 4715 |
|
Other funds holding XFOR
EAM
BCLSI
PA
SVCM
DTC
KCM
VCM
B